Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-24-000120
Filing Date
2024-11-08
Accepted
2024-11-08 07:00:24
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20240930.htm   iXBRL 10-Q 1070095
2 EX-31.1 kprx-20240930xexx311.htm EX-31.1 7435
3 EX-31.2 kprx-20240930xexx312.htm EX-31.2 7460
4 EX-32.1 kprx-20240930xexx321.htm EX-32.1 3847
5 EX-32.2 kprx-20240930xexx322.htm EX-32.2 3861
  Complete submission text file 0001372514-24-000120.txt   6875287

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240930.xsd EX-101.SCH 53807
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20240930_cal.xml EX-101.CAL 75321
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20240930_def.xml EX-101.DEF 285534
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240930_lab.xml EX-101.LAB 740327
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240930_pre.xml EX-101.PRE 491622
71 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240930_htm.xml XML 802164
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 241437953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)